IMARC Group's report titled "Bioabsorbable Stents Market Report by Biomaterial (Polymer-based Bioabsorbable Stents, Metal-based Bioabsorbable Stents), Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Cardiac Centers), and Region 2024-2032". offers a comprehensive analysis of the industry, which comprises insights on the global bioabsorbable stents market report. The global market size reached US$ 409.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 764.2 Million by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/bioabsorbable-stents-market/requestsample
Factors Affecting the Growth of the Bioabsorbable Stents Industry:
- Increasing Prevalence of Cardiovascular Diseases (CVDs):
The rising incidence of conditions, such as coronary artery disease, peripheral artery disease, and other heart-related issues, among the masses due to sedentary lifestyles and dietary habits is contributing to the market growth. Bioabsorbable stents offer a promising solution for the treatment of these diseases, providing temporary support to the vessel walls without the long-term complications associated with metallic stents. This advantage is particularly appealing for patients seeking treatments that reduce future health risks and promote natural vessel healing. Healthcare systems and patients are increasingly prioritizing less invasive interventions with sustainable outcomes, which is driving the demand for bioabsorbable stents.
- Technological Advancements in Stent Development:
Manufacturers are investing in research and development (R&D) to produce stents with improved bioabsorbability, enhanced vessel support, and reduced risk of complications, such as restenosis and thrombosis. These innovations aim to address the limitations of traditional metallic stents by offering a solution that supports the artery during the healing process and then dissolves, leaving no permanent implant behind. This approach not only minimizes long-term complications but also eliminates the need for additional surgeries to remove or replace stents. The rising advances in technology are improving the efficacy, safety, and patient outcomes associated with bioabsorbable stents, making them an attractive option for cardiovascular interventions.
- Shift Towards Minimally Invasive (MI) Procedures:
Minimally invasive (MI) surgeries, including those for cardiovascular interventions, are preferred over traditional open surgeries due to their reduced recovery times, lower risk of infections, and minimal postoperative complications. Bioabsorbable stents are perfectly aligned with this shift, as they can be implanted through less invasive procedures, enhancing patient recovery and satisfaction. This alignment with current medical trends not only increases the adoption of bioabsorbable stents by healthcare providers but also elevates patient preference for such options. The medical community is continuously prioritizing less invasive and more patient-friendly treatment methods, which is catalyzing the demand for bioabsorbable stents.
Leading Companies Operating in the Global Bioabsorbable Stents Industry:
- Abbott Laboratories
- Arterius Limited
- B. Braun SE
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Elixir Medical Corporation
- Kyoto Medical Planning Co. Ltd.
- Lepu Medical Technology (Beijing) Co. Ltd.
- Meril Life Sciences Pvt. Ltd.
- Reva Medical LLC
- Terumo Corporation
Bioabsorbable Stents Market Report Segmentation:
By Biomaterial:
- Polymer-based Bioabsorbable Stents
- Metal-based Bioabsorbable Stents
Polymer-based bioabsorbable stents exhibit a clear dominance in the market accredited to their superior flexibility and biocompatibility, which minimize the risk of arterial irritation and promote better healing.
By Absorption Rate:
- Slow-Absorption Stents
- Fast-Absorption Stents
Slow-absorption stents represent the largest segment, as they provide prolonged support to the artery, reducing the likelihood of vessel recoil and late thrombosis.
By Application:
- Coronary Artery Disease
- Peripheral Artery Disease
Coronary artery disease holds the biggest market share due to the high prevalence of this condition, necessitating advanced treatments like bioabsorbable stents.
By End User:
- Hospitals
- Cardiac Centers
Hospitals account for the majority of the market share attributed to their comprehensive facilities for performing complex stenting procedures and the high volume of patient admissions for cardiovascular diseases.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America dominates the market owing to the existence of an advanced healthcare infrastructure and the presence of leading device manufacturers in the region.
Global Bioabsorbable Stents Market Trends:
The growing integration of drug-eluting technologies with bioabsorbable materials is creating stents that not only support the artery but also deliver therapeutic agents directly to the vessel wall to prevent restenosis. This innovation represents a notable advancement in stent technology, offering dual benefits of mechanical support and localized drug delivery without leaving a permanent implant behind.
Additionally, the advent of personalized medicine and the potential for customizing bioabsorbable stents to individual patient profiles is enhancing their effectiveness and patient outcomes. This trend of more targeted and multifunctional bioabsorbable stents opens new opportunities for manufacturers to innovate and differentiate their products in a competitive market.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
